Follow the 콜마비앤에이치 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 콜마비앤에이치 has published 55 reports. Market capitalisation: €230.9bn. The latest transaction was disclosed on 29 June 2026 (Other). Among the most active insiders: 콜마홀딩스. The full history is free.
54
Insider Decl.
n/a
Thresholds
n/a
13 ops.
Buy Volume
n/a
1 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,688 of 29,057 companies
32.2
score / 100
Value
44
Quality
21
FCF yld6.1%
Earn yld-8.8%
EV/EBITDA·
ROE-0.5%
Gross mgn14%
Net mgn-3.9%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
콜마비앤에이치 opera en el sector de la salud y farmacéutico, cotizada en el mercado XKRX. La empresa se especializa en la fabricación de productos farmacéuticos y sanitarios.